> top > docs > PMC:7102556 > spans > 19008-19998 > annotations

PMC:7102556 / 19008-19998 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
354 99-103 Species denotes CoVs Tax:11118
355 222-230 Species denotes patients Tax:9606
356 236-240 Species denotes CoVs Tax:11118
357 469-477 Species denotes SARS-CoV Tax:694009
358 478-486 Species denotes patients Tax:9606
359 582-590 Species denotes patients Tax:9606
360 638-646 Species denotes MERS-CoV Tax:1335626
361 647-655 Species denotes patients Tax:9606
362 723-731 Species denotes SARS-CoV Tax:694009
363 741-744 Species denotes CoV Tax:11118
364 806-814 Species denotes patients Tax:9606
365 865-873 Species denotes patients Tax:9606
366 936-940 Species denotes CoVs Tax:11118
367 136-146 Chemical denotes nucleoside MESH:D009705
368 245-254 Chemical denotes ribavirin MESH:D012254
369 256-275 Chemical denotes lopinavir/ritonavir MESH:C558899
370 426-435 Chemical denotes ribavirin MESH:D012254
371 502-521 Chemical denotes lopinavir/ritonavir MESH:C558899
372 527-536 Chemical denotes ribavirin MESH:D012254
373 921-930 Disease denotes infection MESH:D007239

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T96 62-65 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T72 469-477 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T73 577-581 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T74 723-731 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T75 921-930 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T207 66-73 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T208 332-340 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T209 701-709 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T122 32-37 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T123 124-129 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T124 136-156 Chemical denotes nucleoside analogues http://purl.obolibrary.org/obo/CHEBI_60783
T125 136-146 Chemical denotes nucleoside http://purl.obolibrary.org/obo/CHEBI_33838
T126 161-177 Chemical denotes immunomodulators http://purl.obolibrary.org/obo/CHEBI_50846
T127 245-254 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T128 256-275 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T129 256-265 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T130 266-275 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T131 322-331 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T132 426-435 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T133 502-521 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T134 502-511 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T135 512-521 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T136 527-536 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T137 691-700 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T138 843-847 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T139 884-889 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T120 0-104 Sentence denotes Similar to developing vaccines, drugs effective against other RNA viruses were also repurposed for CoVs.
T121 105-178 Sentence denotes Two major types of drugs being nucleoside analogues and immunomodulators.
T122 179-309 Sentence denotes So far, the most common therapies tried in patients with CoVs are ribavirin, lopinavir/ritonavir, IFN, or their combinations [74].
T123 310-656 Sentence denotes Despite the antiviral activity observed with in vitro studies, the clinical effect was not consistent [75], in that ribavirin does not prolong the survival of SARS-CoV patients [74,76], while lopinavir/ritonavir plus ribavirin seemed to improve clinical outcomes for SARS patients [77], but the improvement was not confirmed in MERS-CoV patients.
T124 657-823 Sentence denotes IFNs showed effective at inducing antiviral activity against both SARS-CoV and MRES-CoV, but without significant improvement in the outcomes for the patients [78,79].
T125 824-990 Sentence denotes In addition to the drug regimens used in patients, numerous drugs developed for the treatment of infection with CoVs were thoroughly discussed in the literature [57].

2_test

Id Subject Object Predicate Lexical cue
32017984-25278221-69697784 305-307 25278221 denotes 74
32017984-25278221-69697785 488-490 25278221 denotes 74
32017984-26228937-69697786 491-493 26228937 denotes 76
32017984-14985565-69697787 592-594 14985565 denotes 77
32017984-24096239-69697788 816-818 24096239 denotes 78
32017984-14693875-69697789 819-821 14693875 denotes 79
32017984-29143192-69697790 986-988 29143192 denotes 57